Kaleidoscope.bio is a promising startup dedicated to making R&D more collaborative, reproducible, and scalable. The company was founded in 2021 and is headquartered in the United States. Their flagship software allows teams to track their scientific pursuits, collaborate on projects, plan around compounds, candidates, or samples, and manage workflows in a cohesive manner. Recently, the company secured a significant $6.00M Seed Round investment on 28 September 2022 from a cohort of notable investors including Caffeinated Capital, SV Angel, Hummingbird Ventures, Dimension, Hawktail Management, and Nitesh Banta. With its innovative approach and the backing of reputable investors, Kaleidoscope.bio is poised for significant growth and potential impact in the R&D space.
No recent news or press coverage available for Kaleidoscope.bio.